Literature DB >> 33884182

Risk of neurodegenerative disease due to tau phosphorylation changes and arsenic exposure via drinking water.

Davoud Pakzad1, Vajihe Akbari2, Mohammad Reza Sepand3, Mehdi Aliomrani4.   

Abstract

It is estimated that around 140 million people are drinking highly contaminated water with arsenic (As) as a natural earth's crust component. On the other hand, the prevalence of neurodegenerative disorders, especially Alzheimer's disease, is constantly increasing. The aim of the present study was to investigate the correlation between oral arsenic trioxide exposure and its impact on tau protein phosphorylation at Ser262. Fifty-four male mice were randomly divided into three groups and were freely accessed to food and contaminated water of 1 and 10 ppm arsenic trioxide for 3 months, except for control subjects. At the end of each month, As concentration and tau phosphorylation were checked with graphite furnace atomic absorption spectrometer and western blot analysis, respectively. Surprisingly, it was observed that the amount of measured brain arsenic in 10 ppm-exposed subjects was significantly increased after 3 months (P-value ˂ 0.0001). The significant changes in tau phosphorylation were not seen in the 1 ppm-exposed subjects, and it was observed that Ser262 phosphorylation significantly increased after 2 and 3 months in the 10 ppm group (P-value < 0.05). Our results demonstrated that arsenic accumulated in the brain time-dependently and increased Ser262 tau phosphorylation, which is very important in several tauopathies. In conclusion, it could be inferred that environmental arsenic exposure even at very low concentrations could be considered as a reason for increasing the risk of developing neurodegenerative disease.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Alzheimer; arsenic; neurodegenerative disease; phosphorylation; tau; water contamination

Year:  2021        PMID: 33884182      PMCID: PMC8045564          DOI: 10.1093/toxres/tfab011

Source DB:  PubMed          Journal:  Toxicol Res (Camb)        ISSN: 2045-452X            Impact factor:   3.524


  33 in total

1.  Arsenite-induced apoptosis can be attenuated via depletion of mTOR activity to restore autophagy.

Authors:  Chien-Wei Wu; Pei-Jung Lin; Jia-Shiuan Tsai; Chih-Ying Lin; Lih-Yuan Lin
Journal:  Toxicol Res (Camb)       Date:  2018-10-30       Impact factor: 3.524

Review 2.  Tau protein kinases: involvement in Alzheimer's disease.

Authors:  Ludovic Martin; Xenia Latypova; Cornelia M Wilson; Amandine Magnaudeix; Marie-Laure Perrin; Catherine Yardin; Faraj Terro
Journal:  Ageing Res Rev       Date:  2012-06-26       Impact factor: 10.895

3.  Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

Authors:  G T Bramblett; M Goedert; R Jakes; S E Merrick; J Q Trojanowski; V M Lee
Journal:  Neuron       Date:  1993-06       Impact factor: 17.173

Review 4.  A review of arsenic exposure and lung cancer.

Authors:  Shuhui Wei; Hong Zhang; Shasha Tao
Journal:  Toxicol Res (Camb)       Date:  2019-01-23       Impact factor: 3.524

Review 5.  Epidemiology of Alzheimer disease.

Authors:  Christiane Reitz; Carol Brayne; Richard Mayeux
Journal:  Nat Rev Neurol       Date:  2011-02-08       Impact factor: 42.937

6.  Correlation between heavy metal exposure and GSTM1 polymorphism in Iranian multiple sclerosis patients.

Authors:  Mehdi Aliomrani; Mohammad A Sahraian; Hamid Shirkhanloo; Mohammad Sharifzadeh; Mohammad R Khoshayand; Mohammad H Ghahremani
Journal:  Neurol Sci       Date:  2017-04-21       Impact factor: 3.307

7.  Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate.

Authors:  Michael F Hughes; Elaina M Kenyon; Brenda C Edwards; Carol T Mitchell; Luz Maria Del Razo; David J Thomas
Journal:  Toxicol Appl Pharmacol       Date:  2003-09-15       Impact factor: 4.219

Review 8.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

9.  Phosphorylation of nuclear Tau is modulated by distinct cellular pathways.

Authors:  Giorgio Ulrich; Agnese Salvadè; Paul Boersema; Tito Calì; Chiara Foglieni; Martina Sola; Paola Picotti; Stéphanie Papin; Paolo Paganetti
Journal:  Sci Rep       Date:  2018-12-07       Impact factor: 4.379

10.  Tau binding protein CAPON induces tau aggregation and neurodegeneration.

Authors:  Shoko Hashimoto; Yukio Matsuba; Naoko Kamano; Naomi Mihira; Naruhiko Sahara; Jiro Takano; Shin-Ichi Muramatsu; Takaomi C Saido; Takashi Saito
Journal:  Nat Commun       Date:  2019-06-03       Impact factor: 14.919

View more
  2 in total

1.  Creatine and Alpha-Lipoic Acid Antidepressant-Like Effect Following Cyclosporine A Administration

Authors:  Mehdi Aliomrani; Azadeh Mesripour; Abolfazl Saleki Mehrjardi
Journal:  Turk J Pharm Sci       Date:  2022-04-29

Review 2.  Arsenic Exposure through Dietary Intake and Associated Health Hazards in the Middle East.

Authors:  Mohammad Idreesh Khan; Md Faruque Ahmad; Irfan Ahmad; Fauzia Ashfaq; Shadma Wahab; Abdulrahman A Alsayegh; Sachil Kumar; Khalid Rehman Hakeem
Journal:  Nutrients       Date:  2022-05-20       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.